List of Excipients in API BRIVARACETAM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BRIVARACETAM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| UCB Inc | BRIVIACT | brivaracetam | 50474-370 | ANHYDROUS LACTOSE | |
| UCB Inc | BRIVIACT | brivaracetam | 50474-370 | BETADEX | |
| UCB Inc | BRIVIACT | brivaracetam | 50474-370 | CROSCARMELLOSE SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BRIVARACETAM
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 | ANHYDROUS LACTOSE |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 | CELLULOSE, MICROCRYSTALLINE |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 | CROSCARMELLOSE SODIUM |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for BRIVARACETAM
Excipient focus: ANHYDROUS LACTOSE
BRIVARACETAM drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BETADEX
BRIVARACETAM drug variants containing BETADEX
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing BETADEX
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
BRIVARACETAM drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
BRIVARACETAM drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
BRIVARACETAM drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
BRIVARACETAM drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
BRIVARACETAM drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
BRIVARACETAM drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
BRIVARACETAM drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
BRIVARACETAM drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
BRIVARACETAM drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
BRIVARACETAM drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
